Jai Radhakrishnan

Dr. Radhakrishnan is Professor of Medicine at Columbia University Medical Center. He is the Director of Clinical Services of the Nephrology Division. His clinical and research interests are the in the therapy of chronic kidney disease (including glomerular diseases and lupus kidney disease) and intensive care nephrology.

He is a fellow of the American Society of Nephrology and National Kidney Foundation. His commitment to medical education and patient care is exemplified by his numerous teaching awards and his inclusion in the Who's Who among America's Teachers & Educators, America's Best Doctors and Castle Connolly's Top Doctor.

Education & Training

• Jawaharlal Institute - India
• Internship: Lincoln Medical & Mental Health Center
• Residency: Lincoln Medical & Mental Health Center
• Fellowship: Massachusetts General Hospital
• Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Honors & Awards

Teaching Awards

• 1989: Excellence in Teaching - Golden Apple Award, New York Medical College
• 1992: Fellow of the Year - Columbia-Presbyterian Medical Center
• 1994: Junior Attending of the Year, Dept of Medicine
• 2001: Best Morning Report Attending, Dept of Medicine.
• 2003: Senior Attending of the Year, Dept of Medicine
• 2005: Ewig Clinical Education Award, Dept of Medicine.
• 2006: Daniel V. Kimberg Memorial Teaching Award, Dept of Medicine
• 2009: Charles W. Bohmfalk Award for Excellence in Pre-clinical Teaching, Columbia University
• 2010: Member, Glenda Garvey Teaching Academy, Columbia University
• 2010: Outstanding Teacher of the Year, Columbia University, College of Physicians & Surgeons (Preclinical)

Elite Fellowship Programs

• Fellow, American Society of Nephrology
• Fellow, American College of Cardiology
• Member, Royal College of Physicans (UK)

Professional Recognition

• 2007: Whos Who among Americas Teachers & Educators
• 2008, 2009, 2010, 2011: New York Times Magazine Super Doctors
• 2005, 2008, 2010, 2011: Best Doctors in America
• 2008: Who's Who Among Executives and Professionals, Honors Edition
• 2008: Madisons Whos Who
• 2009: Patients Choice Award

Publications

• Radhakrishnan J, Moutzouris DA, Ginzler EM, Solomons N, Siempos II, Appel GB. (2010) Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis. . Kidney Int. 77(2):152-160
• Mohan S, Radhakrishnan J (2011) Geographical variation in the response of lupus nephritis to mycophenolate mofetil induction therapy. Clin Nephrol 75(3):233-41
• Boyden LM, Choi M, Choate KA, et al (2012) Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482(7383):98-102
• Labban B, Arora N, Restaino R, Markowitz G, Valeri A , Radhakrishnan J (2010) The Role of Kidney Biopsy in Heart Transplant Candidates With Kidney Disease Transplantation 89(7):887-893
• Radhakrishnan J, Uppot RN, Colvin RB (2010) Case records of the Massachusetts General Hospital. Case 5-2010. A 51-year-old man with HIV infection, proteinuria, and edema N Engl J Med ;362(7):636-46
• Appel GB, Radhakrishnan J, D'Agati V (2008) Secondary Glomerular Disease BRENNER & RECTOR 8 Ed:1067-1126
• Bhat P, Radhakrishnan J (2008) B lymphocytes and lupus nephritis: New insights into pathogenesis and targeted therapies. Kidney Int 73(3):261-268
• Bomback AS, Smith RJ, Barile GR, Zhang Y, Heher EC, Herlitz L, Stokes MB, Markowitz GS, D'Agati VD, Canetta PA, Radhakrishnan J, Appel GB. (2012) Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis. Clin J Am Soc Nephrol epub: